Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Power List / 2023 / Honorees / Janey L Wiggs

Janey L. Wiggs

  • Profile

About Janey L. Wiggs

Paul Austin Chandler Professor of Ophthalmology, Harvard Medical School, Mass Eye and Ear, USA 

Why did you decide to pursue ophthalmology/your subspecialty?

I liked the combination of medicine and surgery. Also, many eye diseases are inherited and have a strong genetic basis.

What’s been the biggest breakthrough in ophthalmology/your specific field over the last 10 years?

One of the biggest breakthroughs has been the development of polygenic risk scores that use data from genome-wide association studies (GWAS) for glaucoma risk prediction and risk stratification. This work is highly likely to change the way that we practice glaucoma in years to come.

Is there a particular tool, technological advance, or instrument you would not have been able to live without over the past 10 years?

In genetics, the tools and methods change very rapidly, but whole exome/genome sequencing, GWAS and polygenic risk prediction tools are all recent methodological developments in genetics that have made our work possible.

What would you like to see change in ophthalmology/your subspecialty over the next 10 years?

I would like to see increased use of genetic prediction and risk assessment in the clinics, and I do believe that this will happen in the next 10 years.

What is your prediction for where ophthalmology/your subspecialty will be 10 years from now?

We will use genetics for risk prediction in the glaucoma clinic. 

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: